Sensei Biotherapeutics, Inc.
SNSE
$21.45
$0.452.12%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.18M | 25.04M | 28.63M | 34.33M | 41.34M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 231.00K | 496.00K | 828.00K | 911.00K | 474.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 92.00K | 248.00K | 116.00K | 440.00K | 120.00K |
| Total Current Assets | 21.51M | 25.79M | 29.57M | 35.68M | 41.93M |
|
|
|||||
| Total Current Assets | 21.51M | 25.79M | 29.57M | 35.68M | 41.93M |
| Net Property, Plant & Equipment | 1.38M | 1.79M | 2.19M | 2.57M | 3.38M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 18.00K | 18.00K | 24.00K | 24.00K | 48.00K |
| Total Assets | 22.90M | 27.59M | 31.78M | 38.27M | 45.36M |
|
|
|||||
| Total Accounts Payable | 689.00K | 306.00K | 351.00K | 361.00K | 244.00K |
| Total Accrued Expenses | 2.04M | 2.18M | 1.48M | 2.63M | 2.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.45M | 1.88M | 1.96M | 2.15M | 2.32M |
| Total Finance Division Other Current Liabilities | 77.00K | 80.00K | 80.00K | 88.00K | 157.00K |
| Total Other Current Liabilities | 77.00K | 80.00K | 80.00K | 88.00K | 157.00K |
| Total Current Liabilities | 4.25M | 4.44M | 3.87M | 5.23M | 5.45M |
|
|
|||||
| Total Current Liabilities | 4.25M | 4.44M | 3.87M | 5.23M | 5.45M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 59.00K | 146.00K | 596.00K | 1.06M | 1.53M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.31M | 4.58M | 4.47M | 6.29M | 6.98M |
|
|
|||||
| Common Stock & APIC | 301.73M | 301.43M | 301.18M | 300.91M | 300.45M |
| Retained Earnings | -283.14M | -278.42M | -273.85M | -268.92M | -262.05M |
| Treasury Stock & Other | 1.00K | -3.00K | -11.00K | -6.00K | -13.00K |
| Total Common Equity | 18.59M | 23.01M | 27.31M | 31.99M | 38.39M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.59M | 23.01M | 27.31M | 31.99M | 38.39M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.59M | 23.01M | 27.31M | 31.99M | 38.39M |
|
|
|||||